LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles

US Stock Market Move | XPeng Inc. (XPEV.US) rises 7%; XPeng AeroHT X3-F experimental aircraft delivered to the UAE

US Stock Market Move | Positioning in Physical AI opens a new growth curve; Hesai (HSAI.US) rises 8%.

DIAGENS-B (02526) First Post-Listing Equity Incentive Plan Implemented, Share Option Arrangement Demonstrates Development Confidence
US Stock Market Move | XPeng Inc. (XPEV.US) rises 7%; XPeng AeroHT X3-F experimental aircraft delivered to the UAE

US Stock Market Move | Positioning in Physical AI opens a new growth curve; Hesai (HSAI.US) rises 8%.

DIAGENS-B (02526) First Post-Listing Equity Incentive Plan Implemented, Share Option Arrangement Demonstrates Development Confidence






